is...(ListenLearnLead)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
500% revenue growth in Q3! Estimating over 500% revenue growth in Q3!
$BLEG
Third Quarter Looking Great! Finishing strong.$BLEG#acquisition #hemp #solar #solarenergy #CBD #vapes #waterpurifier @brandonspikes55 @PepJ52
500% revenue growth in Q3! Estimating over 500% revenue growth in Q3!
$BLEG
Third Quarter Looking Great! Finishing strong.$BLEG#acquisition #hemp #solar #solarenergy #CBD #vapes #waterpurifier @brandonspikes55 @PepJ52
Super tight float
Check out $BLEG. This thing is tight. volume has increase over the last 2 months. Thing is going to run IMO.
$BLEG & $APRU Branded Legacy, Inc. Partners With Apple Rush Company, Inc. Branded Legacy, Inc. Partners With Apple Rush Company, Inc.
Company Adds New Delta-8 Tincture to Product Line
Company Adds New Delta-8 Tincture to Product Line$BLEG $APRUhttps://t.co/dQOJfhZ3s7@brandonspikes55 @PepJ52
#OTC #trending #Pressrelease #StockMarket #acquisition #StocksToBuy #media #solarpower #delta8 #THCO
$BLEG & $APRU Branded Legacy, Inc. Partners With Apple Rush Company, Inc. Branded Legacy, Inc. Partners With Apple Rush Company, Inc.
Company Adds New Delta-8 Tincture to Product Line
Company Adds New Delta-8 Tincture to Product Line$BLEG $APRUhttps://t.co/dQOJfhZ3s7@brandonspikes55 @PepJ52
#OTC #trending #Pressrelease #StockMarket #acquisition #StocksToBuy #media #solarpower #delta8 #THCO
$BLEG Float is super tight!
Outstanding Shares - 237,482,816 9/9/2022
Restricted - 187,584,929 9/9/2022
Unrestricted - 49,897,887 9/9/2022
Held at DTC - 32,812,13 9/9/2022
Float - 17,085,748 9/9/2022
$BLEG Float is super tight!
Outstanding Shares - 237,482,816 9/9/2022
Restricted - 187,584,929 9/9/2022
Unrestricted - 49,897,887 9/9/2022
Held at DTC - 32,812,13 9/9/2022
Float - 17,085,748 9/9/2022
We need to connect them to $BLEG. Looks like they are looking to get into these products as well. Do you have any connections there?
$BLEG --> The Science Behind NMN–A Stable, Reliable NAD+Activator and Anti-Aging Molecule
In June of 2018, the World Health Organization (WHO) released the 11th edition of its International Classification of Diseases, and for the first time added aging.1 The classification of aging as a disease paves the way for new research into novel therapeutics to delay or reverse age-related illnesses such as cancer, cardiovascular and metabolic disease, and neurodegeneration.2,3 Nutrient sensing systems have been an intense focus of investigation, including mTOR (the mammalian target of rapamycin) for regulating protein synthesis and cell growth; AMPK (activated protein kinase) for sensing low energy states; and sirtuins, a family of seven proteins critical to DNA expression and aging, which can only function in conjunction with NAD+ (nicotinamide adenine dinucleotide), a coenzyme present in all living cells.4
Across the kingdom of life, an increase in intracellular levels of NAD+ triggers shifts that enhance survival, including boosting energy production and upregulating cellular repair.5 In fact, the slow, ineluctable process of aging has been described as a “cascade of robustness breakdown triggered by a decrease in systemic NAD+ biosynthesis and the resultant functional defects in susceptible organs and tissues.”6 Aging is marked by epigenetic shifts, genomic instability, altered nutrient sensing ability, telomere attrition, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and dysregulated intercellular communication.7,8
By middle age, our NAD+ levels have plummeted to half that of our youth.9 Numerous studies have demonstrated that boosting NAD+ levels increases insulin sensitivity, reverses mitochondrial dysfunction, and extends lifespan.10,11 NAD+ levels can be increased by activating enzymes that stimulate synthesis of NAD+, by inhibiting an enzyme (CD38) that degrades NAD+, and by supplementing with NAD precursors, including nicotinamide riboside(NR) and nicotinamide mononucleotide (NMN).12,13 A conceptual framework called NAD World, formulated over the last decade by developmental biologist Shin-ichiro Imai, MD, PhD, of Washington University School of Medicine, posits NMN as a critical, systemic signaling molecule that maintains biological robustness of the communication network supporting NAD+.6
Taken orally, NMN is rapidly absorbed and converted to NAD+.14 In numerous studies, supplementation with NMN has increased NAD+ biosynthesis, suppressed age-related adipose tissue inflammation, enhanced insulin secretion and insulin action, improved mitochondrial function, improved neuronal function in the brain, and more. Here, we look at the science behind NMN, its stability, possible pharmacokinetics, transport, function, and ability to induce biosynthesis of NAD+.15 Supplementing NMN may be an effective nutraceutical anti-aging intervention, with beneficial effects on a wide array of physiological functions.
$BLEG --> The Science Behind NMN–A Stable, Reliable NAD+Activator and Anti-Aging Molecule
In June of 2018, the World Health Organization (WHO) released the 11th edition of its International Classification of Diseases, and for the first time added aging.1 The classification of aging as a disease paves the way for new research into novel therapeutics to delay or reverse age-related illnesses such as cancer, cardiovascular and metabolic disease, and neurodegeneration.2,3 Nutrient sensing systems have been an intense focus of investigation, including mTOR (the mammalian target of rapamycin) for regulating protein synthesis and cell growth; AMPK (activated protein kinase) for sensing low energy states; and sirtuins, a family of seven proteins critical to DNA expression and aging, which can only function in conjunction with NAD+ (nicotinamide adenine dinucleotide), a coenzyme present in all living cells.4
Across the kingdom of life, an increase in intracellular levels of NAD+ triggers shifts that enhance survival, including boosting energy production and upregulating cellular repair.5 In fact, the slow, ineluctable process of aging has been described as a “cascade of robustness breakdown triggered by a decrease in systemic NAD+ biosynthesis and the resultant functional defects in susceptible organs and tissues.”6 Aging is marked by epigenetic shifts, genomic instability, altered nutrient sensing ability, telomere attrition, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and dysregulated intercellular communication.7,8
By middle age, our NAD+ levels have plummeted to half that of our youth.9 Numerous studies have demonstrated that boosting NAD+ levels increases insulin sensitivity, reverses mitochondrial dysfunction, and extends lifespan.10,11 NAD+ levels can be increased by activating enzymes that stimulate synthesis of NAD+, by inhibiting an enzyme (CD38) that degrades NAD+, and by supplementing with NAD precursors, including nicotinamide riboside(NR) and nicotinamide mononucleotide (NMN).12,13 A conceptual framework called NAD World, formulated over the last decade by developmental biologist Shin-ichiro Imai, MD, PhD, of Washington University School of Medicine, posits NMN as a critical, systemic signaling molecule that maintains biological robustness of the communication network supporting NAD+.6
Taken orally, NMN is rapidly absorbed and converted to NAD+.14 In numerous studies, supplementation with NMN has increased NAD+ biosynthesis, suppressed age-related adipose tissue inflammation, enhanced insulin secretion and insulin action, improved mitochondrial function, improved neuronal function in the brain, and more. Here, we look at the science behind NMN, its stability, possible pharmacokinetics, transport, function, and ability to induce biosynthesis of NAD+.15 Supplementing NMN may be an effective nutraceutical anti-aging intervention, with beneficial effects on a wide array of physiological functions.
$BLEG Acquires NMN Company from $RMRK
Astound NMN is an established brand of NMN supplements. These supplements are designed to increase cellular functionality by optimizing the energy cycle and metabolic function. Its signature NMN formulation has the power to reduce age-related effects, increased energy and cognitive function. In addition, it has the ability to improved digestion, metabolism and cardiac function, immune system support, anti-inflammatory abilities, blood sugar regulation, and much more.
Read Full PR
https://tinyurl.com/5dx4c44z
$BLEG Acquires NMN Company from $RMRK
Astound NMN is an established brand of NMN supplements. These supplements are designed to increase cellular functionality by optimizing the energy cycle and metabolic function. Its signature NMN formulation has the power to reduce age-related effects, increased energy and cognitive function. In addition, it has the ability to improved digestion, metabolism and cardiac function, immune system support, anti-inflammatory abilities, blood sugar regulation, and much more.
Read Full PR
https://tinyurl.com/5dx4c44z
$BLEG Acquires Astound NMN from Rimrock Gold Corp. $RMRK
Read Full PR
https://tinyurl.com/5dx4c44z
$BLEG Acquires Astound NMN from Rimrock Gold Corp. $RMRK
Read Full PR
https://tinyurl.com/5dx4c44z
$BLEG Finalized Acquisition
Branded Legacy, Inc. finalized agreement with Thomas “Pepper” Johnson to acquire his patent on a sports training assembly called The Quickness.
"We have been working on this agreement for just over a week now. I can truly tell that the individuals at Branded Legacy are going to be great to work alongside,” stated Pepper Johnson.
$BLEG Finalized Acquisition
Branded Legacy, Inc. finalized agreement with Thomas “Pepper” Johnson to acquire his patent on a sports training assembly called The Quickness.
"We have been working on this agreement for just over a week now. I can truly tell that the individuals at Branded Legacy are going to be great to work alongside,” stated Pepper Johnson.
$BLEG
Branded Legacy, Inc. Eliminates Over 430 Thousand In Debt In 2022
Company Removes All Promissory Notes
Twitter Post
https://tinyurl.com/bdx2sfp5
$BLEG
Branded Legacy, Inc. Eliminates Over 430 Thousand In Debt In 2022
Company Removes All Promissory Notes
Twitter Post
https://tinyurl.com/bdx2sfp5
$BLEG & $APRU Branded Legacy, Inc. Partners With Apple Rush Company, Inc. Branded Legacy, Inc. Partners With Apple Rush Company, Inc.
Company Adds New Delta-8 Tincture to Product Line
Company Adds New Delta-8 Tincture to Product Line$BLEG $APRUhttps://t.co/dQOJfhZ3s7@brandonspikes55 @PepJ52
#OTC #trending #Pressrelease #StockMarket #acquisition #StocksToBuy #media #solarpower #delta8 #THCO
$BLEG & $APRU Branded Legacy, Inc. Partners With Apple Rush Company, Inc. Branded Legacy, Inc. Partners With Apple Rush Company, Inc.
Company Adds New Delta-8 Tincture to Product Line
Company Adds New Delta-8 Tincture to Product Line$BLEG $APRUhttps://t.co/dQOJfhZ3s7@brandonspikes55 @PepJ52
#OTC #trending #Pressrelease #StockMarket #acquisition #StocksToBuy #media #solarpower #delta8 #THCO
$BLEG Float is super tight!
Outstanding Shares - 237,482,816 9/9/2022
Restricted - 187,584,929 9/9/2022
Unrestricted - 49,897,887 9/9/2022
Held at DTC - 32,812,13 9/9/2022
Float - 17,085,748 9/9/2022
$BLEG Float is super tight!
Outstanding Shares - 237,482,816 9/9/2022
Restricted - 187,584,929 9/9/2022
Unrestricted - 49,897,887 9/9/2022
Held at DTC - 32,812,13 9/9/2022
Float - 17,085,748 9/9/2022
$BLEG 500% revenue growth in Q3! Estimating over 500% revenue growth in Q3!
Third Quarter Looking Great! Finishing strong.$BLEG#acquisition #hemp #solar #solarenergy #CBD #vapes #waterpurifier @brandonspikes55 @PepJ52
$BLEG 500% revenue growth in Q3! Estimating over 500% revenue growth in Q3!
Third Quarter Looking Great! Finishing strong.$BLEG#acquisition #hemp #solar #solarenergy #CBD #vapes #waterpurifier @brandonspikes55 @PepJ52
$BLEG 500% revenue growth in Q3! Estimating over 500% revenue growth in Q3!
Third Quarter Looking Great! Finishing strong.$BLEG#acquisition #hemp #solar #solarenergy #CBD #vapes #waterpurifier @brandonspikes55 @PepJ52
$BLEG Tight Float
News has been all great over the last few months
Lowering I/O
Lowering Authorized
This is a winner. IMO
$BLEG Tight Float
News has been all great over the last few months
Lowering I/O
Lowering Authorized
This is a winner. IMO
$BLEG Tight Float
News has been all great over the last few months
Lowering I/O
Lowering Authorized
This is a winner. IMO
$BLEG Update
Twitter
It has been an amazing 2022 thus far. We are in an excellent position.$BLEG@brandonspikes55 @PepJ52 #acquisition #otc #OTCMarkets #hemp #cbd #delta8 #solar #freedom pic.twitter.com/Fmktczn7Mf
— Branded Legacy, Inc. $BLEG (@BrandedLegacy) September 29, 2022
$BLEG Update
Twitter
It has been an amazing 2022 thus far. We are in an excellent position.$BLEG@brandonspikes55 @PepJ52 #acquisition #otc #OTCMarkets #hemp #cbd #delta8 #solar #freedom pic.twitter.com/Fmktczn7Mf
— Branded Legacy, Inc. $BLEG (@BrandedLegacy) September 29, 2022
Should have stuck with the coffee. Thanks for the update. Been trying to reach them with no response.
Always loved the hemp coffee.
$WDRP and $BLEG
some other companies stuff was crap.
I guess Wanderport will continue to wander chasing the new hype market.
Why yes I am. Are you capable knowing what time it is? Lol. More than $500 traded hands yesterday. Wish you the best.
Volume looks good. Did I hear no more coffee?
No more coffee?
That's unfortunate to hear. Volume looks good. How have revenues been?
I'm following cannabis more so. $BLEG is do for big moves.. IMO
Wish you the best.
Come on $BLEG
Time to run......... Lol
$BLEG Branded Legacy, Inc. Reduces Authorized Shares By 300 Million
Company Receives Approval To Reduce Authorized Shares
Orlando, FL -- September 27, 2022 -- InvestorsHub NewsWire -- Branded Legacy, Inc. (OTCPK: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce the approval to reduce its authorized shares by Three Hundred Million (300,000,000).
Branded Legacy, Inc. received majority shareholder consent and board approval for the reduction in its authorized shares. The reduction will bring the Authorized Common Shares down to Six Hundred Million (600,000,000).
The Company has been working to improve its share structure as well as increase its shareholder value through many transactions such as reducing its debt as well as reducing the amount of issued and outstanding. The Company has lowered its liabilities by four hundred and thirty-six thousand one hundred and nineteen dollars ($436,119) in 2022 and reduced its issued and outstanding common shares by Two Hundred and Two Million (202,000,000) in the month of August.
Brandon Spikes, chairman of Branded Legacy, Inc., stated, “I couldn’t be more pleased with the progress that we have made. Our shareholders are very important to us, and we are diligently working to ensure the success of this Company.”
$BLEG Branded Legacy, Inc. Reduces Authorized Shares By 300 Million
Company Receives Approval To Reduce Authorized Shares
Orlando, FL -- September 27, 2022 -- InvestorsHub NewsWire -- Branded Legacy, Inc. (OTCPK: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce the approval to reduce its authorized shares by Three Hundred Million (300,000,000).
Branded Legacy, Inc. received majority shareholder consent and board approval for the reduction in its authorized shares. The reduction will bring the Authorized Common Shares down to Six Hundred Million (600,000,000).
The Company has been working to improve its share structure as well as increase its shareholder value through many transactions such as reducing its debt as well as reducing the amount of issued and outstanding. The Company has lowered its liabilities by four hundred and thirty-six thousand one hundred and nineteen dollars ($436,119) in 2022 and reduced its issued and outstanding common shares by Two Hundred and Two Million (202,000,000) in the month of August.
Brandon Spikes, chairman of Branded Legacy, Inc., stated, “I couldn’t be more pleased with the progress that we have made. Our shareholders are very important to us, and we are diligently working to ensure the success of this Company.”
$BLEG Branded Legacy, Inc. Reduces Authorized Shares By 300 Million
Company Receives Approval To Reduce Authorized Shares
Orlando, FL -- September 27, 2022 -- InvestorsHub NewsWire -- Branded Legacy, Inc. (OTCPK: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce the approval to reduce its authorized shares by Three Hundred Million (300,000,000).
Branded Legacy, Inc. received majority shareholder consent and board approval for the reduction in its authorized shares. The reduction will bring the Authorized Common Shares down to Six Hundred Million (600,000,000).
The Company has been working to improve its share structure as well as increase its shareholder value through many transactions such as reducing its debt as well as reducing the amount of issued and outstanding. The Company has lowered its liabilities by four hundred and thirty-six thousand one hundred and nineteen dollars ($436,119) in 2022 and reduced its issued and outstanding common shares by Two Hundred and Two Million (202,000,000) in the month of August.
Brandon Spikes, chairman of Branded Legacy, Inc., stated, “I couldn’t be more pleased with the progress that we have made. Our shareholders are very important to us, and we are diligently working to ensure the success of this Company.”